Lo scopo di questo lavoro è quello di valutare la spettroscopia, quale tecnica di indagine neuroradiologica, prendendone in esame i vari aspetti. Per fare ciò vengono illustrate dapprima le basi fisiche, quindi quelle tecniche per poi passare alle basi neurobiologiche.
Nella seconda parte dell'articolo si esaminano le applicazioni cliniche facendo in particolare riferimento alla propria esperienza diretta. Le patologie considerate sono quella tumorale, la demielinizzante, l'epilessia e le malattie infettive. Dall'analisi di questi dati, congiuntamente alle esperienze riportate in letteratura si tenta di giungere alla definizione delle potenzialità e dell'effettivo ruolo di questa tecnica in ambito clinico.
SauterRSchneiderM: Current status of clinically relevant techniques in magnetic resonance spectroscopy. Electromedica60: 32–54, 1992.
10.
BrownTRKincaidBMUgurbilK: NMR chemical shift imaging in three dimensions. Proc Natl Acc Sci USA79: 3523–3526, 1982.
11.
PrichardJW: NMR spectroscopy of cerebral metabolism in vivo. Medical Magnetic Resonance, Ed by BudingerTF and MargulisAR, NY, USA1988: 309–324.
12.
MillerBL: A review of chemical issues in 1 H NMR spectroscopy: N-acetyl-L-aspartate, Creatine and Choline. NMR Biomed4: 47–52, 1991.
13.
MichaelisTMerboldtKD: Absolute concentratios of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology187: 219–227, 1993.
14.
KnaapMSGrondJV: Age dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology176: 509–515, 1990.
15.
SiesjoBKFolbergrovJ: The effect of hypercapnia upon intracellular Ph in the brain, evaluated by the bicarbonate-carbonic acid method and from the creatine phosphokinase equilibrium. J Neurochem19: 2483–2495, 1971.
16.
NadlerJVCooperJR: N-Acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem19: 313–319, 1982.
17.
FrahmJBruhnH: Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentration of cerebral metabolites. Magn Reson Med11: 47–63, 1989.
18.
FrahmJBruhnH: Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Res Med9: 79–93, 1989.
19.
HanstockCCRothmanDL: Spatially localized 1H NMR spectra of metabolites in the human brain. PNAS85: 1821–25, 1988.
20.
BirkenDLOldendorfWH: N-acetyl-l-aspartate: a litteratue review of a compound prominent in 1 H NMR spectroscopic studies of the brain. Neurosci Biobehav Rev13: 23–31, 1989.
21.
SegebarthCMBaleriauxDF: Detection of metabolic heterogeneity of human intracranial tumors in vivo by H1 NMR Spectroscopic imaging. Magn Reson Med13: 62–76, 1990.
22.
CadyEB: Determination of absolute concentrations of metabolites from NMR spectra. NMR Basic Principles and Progress26: 249–82, 1992.
23.
HenningJPfisterH: Direct absolute quantification of metabolites in the human brain with in vivo localised proton spectroscopy. NMR Biomed5: 193–99, 1992.
24.
FrahmJBruhnH: Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. J Comput Assist Tomogr15: 915–22, 1991.
25.
GadianDGBatesTE: Approaches to editing, assignment and interpretation of proton spectra. NMR Biomed4: 47–116, 1991.
26.
LuytenPRMarienAJH: Metabolic imaging of patients with intracranial tumors: H1-MR spectroscopy imaging and PET. Radiology176: 791–799, 1990.
27.
AlgerJRFrankJA: Metabolism of human gliomas: assessment with H1-MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology177: 633–641, 1990.
HeindellWHerholzK: Combined H1-MR spectroscopy imaging and F-18 FDG-PET demonstrate metabolic states that imply malignancy in human gliomas. Syllabus SMRM, XI Annual Meeting, Berlino 1992: 51.
30.
GideonPHenriksenO: Reappearance of lactate in chronic infarction measured by H1-MRS. Syllabus SMRM, XI Annual Meeting, Berlino, 1908, 1992.
31.
JohannikDemerel P: Localized H1-MR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr15: 67–76, 1991.
32.
BruhnHFrahmJ: Noninvasive differentation of tumors with use of localized H1-MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology127: 541–548, 1989.
33.
RichardsTL: Proton MR Spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression and evaluating therapy. Am J Radiology157: 1073–1078, 1991.
34.
LarssonHBWChristiansenP: Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med22: 23–31, 1991.
35.
MatthewsPMFrancisG: Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology41: 1251–56, 1991.
36.
ArnoldDLMatthewsPM: Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assesment of the load disease. Magn Reson Med14: 154–159, 1990.
37.
GiangDWPoduriKR: Multiple sclerosis masquerating as a mass lesion. Neuroradiology34: 150–154, 1992.
38.
KepesJJ: Large focal tumor like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol33: 18–27, 1993.
39.
CampiAFaliniA: Valutazione seriata con RM e Spettroscopia RM (H1-MRS) di un caso ad esordio pseudotumorale. In: ScottiG: Neuroradiologia 1992. Edizioni del Centauro, Udine1992, Vol II: 297–304.
40.
GrossmanRILenkiskiRE: MR proton spectroscopy in multiple sclerosis. Am J Neuroradiol13: 1535–1543, 1992.
41.
SperlingMRWilsonG: Magnetic Resonance imaging in intractable partial epilepsy: correlative studies. Ann Neurol20: 57–62, 1986.
42.
HuggJWLaxerKD: Lateralization of human focal epilepsy by 31 P magnetic resonance spectroscopic imaging. Neurology42: 2011–2018, 1992.
43.
PeelingJSutherlandG: H Magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus. Neurology43: 589–594, 1993.
44.
ConnellyAJacksonGD: The Contribution of H1-MRS to the presurgical assessment of temporal lobe pathology in patients with intractable epilepsy. Syllabus SMRM, XII Annual Scientific Meeting, New York 1993: 1463.
45.
MeldrumBSCorsellisJAN: Epilepsy. AdamsJHCorselisJANDuchenLWGreenfield's neuropathology, 4th edition. Edward Arnold, London1984: 921–950.
46.
HolmesGL: Do seizure cause brain damage?Epilepsia32 (suppl 5): S14–S28, 1991.
47.
GrayFGherardiR: The neuropathology of the acquired immune deficiency syndrome (AIDS). Brain111: 245–266, 1988.
48.
KetzlerSWeissS: Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl)80: 92–94, 1990.
49.
EverallIPLuthertPJ: Neuronal loss in the frontal cortex in the HIV infection. Lancet337: 1119–1121, 1991.
50.
WileyCAMasliahE: Neocortical damage during HIV infection. Ann Neurol29: 651–657, 1991.
51.
PriceRWSidtisJ: The AIDS dementia complex: some current questions. Ann Neurol23 (suppl): S27–S33, 1988.
52.
ChrysikopoulosHSPressGA: Encephalitis caused by immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology175: 185–191, 1990.
53.
Spinnler: Il deterioramento Demenziale. Manuale di neuropsicologia, Denes G e Pizzamiglio L. Zanichelli ed, Bologna1991: 889–901.
DeickenRFHubeshB: Alterations in brain phosphate metabolite concentrations in patients with human immunodeficiency virus infection. Arch Neurol48: 203–209, 1991.
56.
SchmittFABigleyJW: Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med319: 1573–1578, 1988.
